TW202302083A - 檸檬酸鐵用於治療缺鐵性貧血之用途 - Google Patents
檸檬酸鐵用於治療缺鐵性貧血之用途 Download PDFInfo
- Publication number
- TW202302083A TW202302083A TW111133966A TW111133966A TW202302083A TW 202302083 A TW202302083 A TW 202302083A TW 111133966 A TW111133966 A TW 111133966A TW 111133966 A TW111133966 A TW 111133966A TW 202302083 A TW202302083 A TW 202302083A
- Authority
- TW
- Taiwan
- Prior art keywords
- iron
- ferric citrate
- months
- patient
- weeks
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562127963P | 2015-03-04 | 2015-03-04 | |
| US62/127,963 | 2015-03-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202302083A true TW202302083A (zh) | 2023-01-16 |
Family
ID=56848619
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW111133966A TW202302083A (zh) | 2015-03-04 | 2016-03-03 | 檸檬酸鐵用於治療缺鐵性貧血之用途 |
| TW105106564A TWI812580B (zh) | 2015-03-04 | 2016-03-03 | 檸檬酸鐵用於治療缺鐵性貧血之用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW105106564A TWI812580B (zh) | 2015-03-04 | 2016-03-03 | 檸檬酸鐵用於治療缺鐵性貧血之用途 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20180071243A1 (enExample) |
| EP (1) | EP3265077A4 (enExample) |
| JP (2) | JP2018507260A (enExample) |
| KR (1) | KR20170123664A (enExample) |
| CN (1) | CN107530310A (enExample) |
| AU (1) | AU2016226250B2 (enExample) |
| BR (1) | BR112017018963A2 (enExample) |
| CA (1) | CA2978073A1 (enExample) |
| EA (1) | EA201791960A1 (enExample) |
| HK (2) | HK1248589A1 (enExample) |
| IL (1) | IL254125A0 (enExample) |
| MX (1) | MX2017011169A (enExample) |
| SG (1) | SG11201707120PA (enExample) |
| TW (2) | TW202302083A (enExample) |
| WO (1) | WO2016141124A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120046753A (ko) | 2009-07-21 | 2012-05-10 | 케릭스 바이오파마슈티컬스 인코포레이티드 | 구연산철 투여형태 |
| US20210085711A1 (en) * | 2017-09-19 | 2021-03-25 | Japan Tobacco Inc. | Use of ferric citrate in prevention and/or treatment of iron-deficiency anemia in hypermenorrhea patient and/or patient suffering from hypermenorrhea-associated gynecologic disease |
| FR3075601A1 (fr) * | 2017-12-21 | 2019-06-28 | Clarisse Le Court | Complements alimentaires et leur utilisation sur les menstruations |
| US12467933B2 (en) | 2019-06-07 | 2025-11-11 | Arizona Board Of Regents On Behalf Of Arizona State University | Body fluid iron level panel analyzer |
| EP4347022A1 (en) | 2021-05-27 | 2024-04-10 | Keryx Biopharmaceuticals, Inc. | Pediatric formulations of ferric citrate |
| WO2023047424A1 (en) * | 2022-04-29 | 2023-03-30 | West Bengal Chemical Industries Limited | Pharmaceutical acceptable iron (iii) coordination complex having high phosphate binding capacity and preparation thereof |
| KR102623739B1 (ko) * | 2022-07-28 | 2024-01-11 | 주식회사 페라메드 | 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI335218B (en) * | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| US8093423B2 (en) * | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| JP4931352B2 (ja) * | 2004-01-14 | 2012-05-16 | 月桂冠株式会社 | 鉄補給剤及びその利用 |
| CA2552889A1 (en) * | 2004-01-14 | 2005-07-28 | Sachiko Suzuki | Iron supplement and utilization of the same |
| NZ566743A (en) * | 2005-08-18 | 2010-07-30 | Globoasia Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
| WO2012097155A1 (en) * | 2011-01-14 | 2012-07-19 | Chiasma Inc. | Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof |
| SG11201408521WA (en) * | 2012-06-21 | 2015-01-29 | Keryx Biopharmaceuticals Inc | Use of ferric citrate in the treatment of chronic kidney disease patients |
-
2016
- 2016-03-03 CN CN201680025431.0A patent/CN107530310A/zh active Pending
- 2016-03-03 US US15/553,348 patent/US20180071243A1/en not_active Abandoned
- 2016-03-03 EP EP16759457.1A patent/EP3265077A4/en not_active Ceased
- 2016-03-03 MX MX2017011169A patent/MX2017011169A/es unknown
- 2016-03-03 HK HK18108472.0A patent/HK1248589A1/zh unknown
- 2016-03-03 SG SG11201707120PA patent/SG11201707120PA/en unknown
- 2016-03-03 BR BR112017018963A patent/BR112017018963A2/pt not_active Application Discontinuation
- 2016-03-03 TW TW111133966A patent/TW202302083A/zh unknown
- 2016-03-03 JP JP2017564757A patent/JP2018507260A/ja active Pending
- 2016-03-03 AU AU2016226250A patent/AU2016226250B2/en not_active Expired - Fee Related
- 2016-03-03 EA EA201791960A patent/EA201791960A1/ru unknown
- 2016-03-03 CA CA2978073A patent/CA2978073A1/en not_active Abandoned
- 2016-03-03 TW TW105106564A patent/TWI812580B/zh active
- 2016-03-03 KR KR1020177027533A patent/KR20170123664A/ko not_active Ceased
- 2016-03-03 HK HK18106104.0A patent/HK1246649A1/zh unknown
- 2016-03-03 WO PCT/US2016/020575 patent/WO2016141124A1/en not_active Ceased
-
2017
- 2017-08-23 IL IL254125A patent/IL254125A0/en unknown
-
2021
- 2021-01-26 JP JP2021010151A patent/JP2021091686A/ja active Pending
-
2022
- 2022-12-21 US US18/069,555 patent/US20240075006A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1246649A1 (zh) | 2018-09-14 |
| JP2018507260A (ja) | 2018-03-15 |
| KR20170123664A (ko) | 2017-11-08 |
| WO2016141124A1 (en) | 2016-09-09 |
| CN107530310A (zh) | 2018-01-02 |
| BR112017018963A2 (pt) | 2018-05-15 |
| EP3265077A1 (en) | 2018-01-10 |
| HK1248589A1 (zh) | 2018-10-19 |
| EP3265077A4 (en) | 2018-10-24 |
| TW201639558A (zh) | 2016-11-16 |
| TWI812580B (zh) | 2023-08-21 |
| EA201791960A1 (ru) | 2018-01-31 |
| US20240075006A1 (en) | 2024-03-07 |
| SG11201707120PA (en) | 2017-09-28 |
| CA2978073A1 (en) | 2016-09-09 |
| MX2017011169A (es) | 2017-11-09 |
| JP2021091686A (ja) | 2021-06-17 |
| AU2016226250A1 (en) | 2017-09-28 |
| IL254125A0 (en) | 2017-10-31 |
| US20180071243A1 (en) | 2018-03-15 |
| AU2016226250B2 (en) | 2021-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018203205B2 (en) | Use of ferric citrate in the treatment of chronic kidney disease patients | |
| AU2016226250B2 (en) | Use of ferric citrate in the treatment of iron-deficiency anemia | |
| JP6828100B2 (ja) | 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 | |
| JPWO2019059172A1 (ja) | 過多月経患者及び／又は過多月経を伴う婦人科疾患を有する患者における鉄欠乏性貧血の予防及び／又は治療におけるクエン酸第二鉄の使用 | |
| HK1210013B (en) | Use of ferric citrate in the treatment of chronic kidney disease patients |